NO874632L - Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel. - Google Patents

Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel.

Info

Publication number
NO874632L
NO874632L NO87874632A NO874632A NO874632L NO 874632 L NO874632 L NO 874632L NO 87874632 A NO87874632 A NO 87874632A NO 874632 A NO874632 A NO 874632A NO 874632 L NO874632 L NO 874632L
Authority
NO
Norway
Prior art keywords
cyclodextrinclathrates
medicine
carbacycline derivatives
carbacycline
derivatives
Prior art date
Application number
NO87874632A
Other languages
English (en)
Other versions
NO173440C (no
NO173440B (no
NO874632D0 (no
Inventor
Werner Skuballa
Helmut Vorbruggen
Helmut Dahl
Claus-Steffen Sturzebecher
Karl-Heinz Thierauch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO874632D0 publication Critical patent/NO874632D0/no
Publication of NO874632L publication Critical patent/NO874632L/no
Publication of NO173440B publication Critical patent/NO173440B/no
Publication of NO173440C publication Critical patent/NO173440C/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO874632A 1986-03-07 1987-11-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive cyclodextrinclathrater av carbacyclinanaloger NO173440C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3608088A DE3608088C2 (de) 1986-03-07 1986-03-07 Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
PCT/DE1987/000106 WO1987005294A1 (en) 1986-03-07 1987-03-09 Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs

Publications (4)

Publication Number Publication Date
NO874632D0 NO874632D0 (no) 1987-11-06
NO874632L true NO874632L (no) 1987-11-06
NO173440B NO173440B (no) 1993-09-06
NO173440C NO173440C (no) 1993-12-15

Family

ID=6296073

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874632A NO173440C (no) 1986-03-07 1987-11-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive cyclodextrinclathrater av carbacyclinanaloger

Country Status (22)

Country Link
US (1) US4886788A (no)
EP (1) EP0259468B1 (no)
JP (2) JPH07107020B2 (no)
AT (1) AT397084B (no)
AU (2) AU609390B2 (no)
CA (1) CA1309087C (no)
CH (1) CH672313A5 (no)
CS (1) CS270558B2 (no)
DD (1) DD258942A5 (no)
DE (3) DE3608088C2 (no)
ES (1) ES2004543A6 (no)
FI (1) FI92388C (no)
GB (2) GB2189783A (no)
GR (1) GR870363B (no)
HU (1) HU198906B (no)
IE (1) IE59760B1 (no)
IL (1) IL81802A (no)
NO (1) NO173440C (no)
NZ (1) NZ219508A (no)
SU (1) SU1632371A3 (no)
WO (1) WO1987005294A1 (no)
ZA (1) ZA871663B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663316A (en) * 1985-06-28 1987-05-05 Warner-Lambert Company Antibiotic clathrates and pharmaceutical compositions thereof
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
DE3933523A1 (de) * 1989-10-05 1991-04-11 Schering Ag Antimetastatisch wirkende mittel
DE4010355A1 (de) * 1990-03-28 1991-10-02 Schering Ag Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE4104606C1 (no) * 1991-02-12 1992-10-15 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US5221735A (en) * 1991-02-25 1993-06-22 Hoffmann-La Roche Inc. Cyclodextrin-polyene inclusion complexes
DE4135193C1 (no) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US6103403A (en) * 1997-05-15 2000-08-15 University Of Kentucky Research Foundation Intellectual Property Development Clathrate structure for electronic and electro-optic applications
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
DE19828881A1 (de) * 1998-06-22 1999-12-23 Schering Ag Oxidationsinhibitor bei Prostan-Derivaten
DE10225551A1 (de) * 2002-06-06 2003-12-24 Schering Ag Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
MY158766A (en) * 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (es) * 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
TW200730474A (en) 2005-12-29 2007-08-16 Schering Ag Diamine derivatives as inhibitors of leukotriene A4 hydrolease
JPWO2008018592A1 (ja) * 2006-08-11 2010-01-07 大正製薬株式会社 プロスタグランジン誘導体含有外用剤
CL2007002950A1 (es) 2006-10-12 2008-02-01 Xenon Pharmaceuticals Inc Uso de compuestos derivados de espiro-oxindol en el tratamiento de hipercolesterolemia, hiperplasia benigna de prostata, pruritis, cancer
US20110294842A9 (en) * 2006-10-12 2011-12-01 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
EP2350091B1 (en) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
US8263606B2 (en) 2008-10-17 2012-09-11 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
EP2733145A1 (en) 2009-10-14 2014-05-21 Xenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
WO2011047173A2 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
PE20121699A1 (es) 2010-02-26 2012-12-22 Xenon Pharmaceuticals Inc Composiciones farmaceuticas del compuesto espiro-oxindol para administracion topica
CN104350057A (zh) 2012-04-12 2015-02-11 泽农医药公司 用作治疗剂的螺-羟吲哚化合物的不对称合成
WO2014152229A2 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
WO2016127068A1 (en) 2015-02-05 2016-08-11 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
WO2017218920A1 (en) 2016-06-16 2017-12-21 Teva Pharmaceuticals International Gmbh Asymmetric synthesis of funapide
WO2018107167A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolase
JP7174700B2 (ja) 2016-12-09 2022-11-17 セルタクシー、エルエルシー ロイコトリエンa4ヒドロラーゼの阻害剤としてのモノアミン及びモノアミン誘導体
WO2018107153A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
HU231212B1 (hu) * 2018-04-16 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás iloprost előállítására
RU2741848C1 (ru) * 2019-03-16 2021-01-29 Иванова Мария Ивановна Способ получения клатратных комплексов летучих веществ
CN117881648A (zh) * 2021-09-13 2024-04-12 富士胶片株式会社 双环烷烃化合物的包合物的制造方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (no) * 1970-06-10 1975-02-04
AU476695B2 (en) * 1974-01-15 1975-07-17 Ono Pharmaceutical Co. Ltd Clathrate prostaglandins and compositions containing same
HU179141B (no) * 1977-09-23 1982-08-28
DE2912409A1 (de) * 1978-03-31 1979-10-11 Ono Pharmaceutical Co 6,9-methano-pgi tief 2 -analoge
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS56150039A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Clathrate compound of prostacycline derivative
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS5818357A (ja) * 1981-07-28 1983-02-02 Ono Pharmaceut Co Ltd 6,9−メタノ−pgi↓2及び6,9−メタノ−pgi↓2類似化合物の安定化組成物及びその製造方法
JPS58116423A (ja) * 1981-12-28 1983-07-11 Sumitomo Chem Co Ltd メタノプロスタサイクリン製剤組成物
JPS58192821A (ja) * 1982-04-30 1983-11-10 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患の治療剤
JPS58216140A (ja) * 1982-05-28 1983-12-15 メイ・アンド・ベイカ−・リミテツド 新規なプロスタグランジン類似体
JPS59141536A (ja) * 1983-02-01 1984-08-14 Sumitomo Chem Co Ltd 新規ビシクロオクタン誘導体
DE3306123A1 (de) * 1983-02-18 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
FR2547818B1 (fr) * 1983-05-24 1986-09-05 May & Baker Ltd Nouveaux analogues de prostaglandines, leur preparation, les compositions pharmaceutiques qui les contiennent et les intermediaires-cles pour les preparer
DE3405181A1 (de) * 1984-02-10 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0171992B1 (en) * 1984-08-09 1990-06-06 Mitsubishi Kasei Corporation Pharmaceuticals containing prostaglandin i2
JPS6144819A (ja) * 1984-08-09 1986-03-04 Sagami Chem Res Center プロスタグランジンi2類縁化合物を含有する循環改善作用を有する薬剤
US4757087A (en) * 1985-03-19 1988-07-12 Sankyo Company Limited Carbacyclin derivatives
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten

Also Published As

Publication number Publication date
WO1987005294A1 (en) 1987-09-11
AU7160987A (en) 1987-09-28
IE870586L (en) 1987-09-07
NO173440C (no) 1993-12-15
JPH08193046A (ja) 1996-07-30
JP2634787B2 (ja) 1997-07-30
GB2199031A (en) 1988-06-29
IL81802A (en) 1991-07-18
IL81802A0 (en) 1987-10-20
FI874406A0 (fi) 1987-10-07
FI874406A (fi) 1987-10-07
NZ219508A (en) 1990-08-28
FI92388C (fi) 1994-11-10
HU198906B (en) 1989-12-28
EP0259468B1 (de) 1991-05-15
DE3770085D1 (de) 1991-06-20
NO173440B (no) 1993-09-06
ATA900787A (de) 1993-06-15
NO874632D0 (no) 1987-11-06
FI92388B (fi) 1994-07-29
DD258942A5 (de) 1988-08-10
ES2004543A6 (es) 1989-01-16
AU6988687A (en) 1987-09-10
AU609390B2 (en) 1991-05-02
SU1632371A3 (ru) 1991-02-28
AT397084B (de) 1994-01-25
GB2199031B (en) 1990-01-10
GB2189783A (en) 1987-11-04
JPH07107020B2 (ja) 1995-11-15
EP0259468A1 (de) 1988-03-16
CH672313A5 (no) 1989-11-15
CS151187A2 (en) 1989-11-14
US4886788A (en) 1989-12-12
ZA871663B (en) 1987-08-28
CS270558B2 (en) 1990-07-12
GB8704982D0 (en) 1987-04-08
IE59760B1 (en) 1994-03-23
DE3790121D2 (en) 1988-03-10
DE3608088A1 (de) 1987-09-10
GR870363B (en) 1987-06-30
CA1309087C (en) 1992-10-20
JPS63502665A (ja) 1988-10-06
DE3608088C2 (de) 1995-11-16
GB8725695D0 (en) 1987-12-09
HUT45484A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
NO874632L (no) Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel.
DK267489A (da) 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler
DK143588A (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
DK143284D0 (da) Thiazolinderivater,deres fremstilling og anvendelse som laegemiddel
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
DK633287D0 (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK366888D0 (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
DK235787A (da) Tripeptidderivater, deres fremstilling og anvendelse
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK73287A (da) Insulinderivater, deres fremstilling og anvendelse
NO870639D0 (no) Benzimidazolderivater og deres anvendelse som fungicider.
DK213387D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK627684A (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK42888D0 (da) Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel
DK208886A (da) (1,4)-benzodioxin- og (1,4)-benzoxazinderivater deres fremstilling og anvendelse som laegemidler
DK212687D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK648389A (da) Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler
DK501888D0 (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
DK610787A (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
DK37787D0 (da) 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler
DK278290A (da) Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DK288989D0 (da) Cholestadienderivater, deres fremstilling og anvendelse som laegemidler
DK111887A (da) Aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater, deres fremstilling og anvendelse som laegemidler